 Timothy Whitehead
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Engineering | 12 | 2023 | 107 | 5.740 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2018 | 449 | 2.130 |
Why?
| | Epitope Mapping | 5 | 2018 | 49 | 2.090 |
Why?
| | Biotechnology | 5 | 2023 | 46 | 2.010 |
Why?
| | Escherichia coli | 12 | 2020 | 757 | 1.990 |
Why?
| | Mutation | 12 | 2022 | 3435 | 1.920 |
Why?
| | Proteins | 9 | 2022 | 935 | 1.890 |
Why?
| | Gene Library | 8 | 2023 | 125 | 1.850 |
Why?
| | Epitopes | 5 | 2020 | 439 | 1.800 |
Why?
| | Antibodies, Monoclonal | 5 | 2024 | 1279 | 1.740 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 94 | 1.720 |
Why?
| | DNA | 3 | 2023 | 1385 | 1.480 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2022 | 363 | 1.380 |
Why?
| | Mutagenesis | 8 | 2023 | 176 | 1.350 |
Why?
| | Saccharomyces cerevisiae | 4 | 2021 | 494 | 1.300 |
Why?
| | Genetic Fitness | 2 | 2019 | 55 | 1.260 |
Why?
| | Antibodies | 3 | 2019 | 381 | 1.130 |
Why?
| | Plasmids | 5 | 2023 | 355 | 1.090 |
Why?
| | Synthetic Biology | 2 | 2023 | 10 | 1.070 |
Why?
| | Cell Adhesion Molecules | 2 | 2018 | 177 | 1.070 |
Why?
| | Lignin | 2 | 2016 | 53 | 1.040 |
Why?
| | Amidohydrolases | 3 | 2019 | 29 | 0.980 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 748 | 0.970 |
Why?
| | Molecular Chaperones | 5 | 2009 | 173 | 0.970 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2021 | 138 | 0.960 |
Why?
| | DNA Mutational Analysis | 2 | 2021 | 379 | 0.930 |
Why?
| | DNA, Single-Stranded | 2 | 2023 | 114 | 0.880 |
Why?
| | Models, Molecular | 17 | 2020 | 1434 | 0.870 |
Why?
| | Phosphotransferases | 3 | 2017 | 27 | 0.870 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2021 | 72 | 0.850 |
Why?
| | Directed Molecular Evolution | 1 | 2022 | 25 | 0.830 |
Why?
| | beta-Lactamases | 3 | 2017 | 26 | 0.820 |
Why?
| | Immunoglobulin Variable Region | 1 | 2021 | 72 | 0.810 |
Why?
| | Protein Binding | 14 | 2021 | 1969 | 0.800 |
Why?
| | Green Fluorescent Proteins | 4 | 2019 | 394 | 0.780 |
Why?
| | Binding Sites | 9 | 2022 | 1221 | 0.780 |
Why?
| | Oncostatin M Receptor beta Subunit | 1 | 2020 | 1 | 0.760 |
Why?
| | Bioengineering | 1 | 2020 | 13 | 0.750 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 170 | 0.750 |
Why?
| | Receptors, Interleukin | 1 | 2020 | 40 | 0.740 |
Why?
| | Antibodies, Neutralizing | 3 | 2021 | 225 | 0.730 |
Why?
| | Personality | 1 | 2021 | 115 | 0.720 |
Why?
| | Biochemistry | 1 | 2020 | 40 | 0.720 |
Why?
| | Atropa belladonna | 1 | 2019 | 1 | 0.690 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2019 | 139 | 0.690 |
Why?
| | Protein Folding | 3 | 2019 | 250 | 0.680 |
Why?
| | Acyltransferases | 1 | 2019 | 52 | 0.670 |
Why?
| | Mutant Proteins | 2 | 2018 | 100 | 0.660 |
Why?
| | Interleukins | 1 | 2020 | 242 | 0.650 |
Why?
| | Cell Surface Display Techniques | 1 | 2018 | 10 | 0.650 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 28 | 0.640 |
Why?
| | Yeasts | 1 | 2018 | 52 | 0.640 |
Why?
| | Carrier Proteins | 1 | 2022 | 725 | 0.630 |
Why?
| | Computational Biology | 6 | 2015 | 541 | 0.620 |
Why?
| | Metabolic Engineering | 2 | 2014 | 26 | 0.620 |
Why?
| | Gene Products, tat | 1 | 2017 | 21 | 0.600 |
Why?
| | Clostridium cellulolyticum | 1 | 2016 | 1 | 0.590 |
Why?
| | Clostridium thermocellum | 1 | 2016 | 3 | 0.590 |
Why?
| | Cellulase | 1 | 2016 | 35 | 0.570 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2016 | 103 | 0.550 |
Why?
| | Point Mutation | 1 | 2016 | 227 | 0.540 |
Why?
| | Software | 4 | 2016 | 566 | 0.540 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 122 | 0.530 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2012 | 20 | 0.530 |
Why?
| | Selection, Genetic | 1 | 2017 | 252 | 0.520 |
Why?
| | Coumaric Acids | 1 | 2014 | 3 | 0.520 |
Why?
| | Liquid-Liquid Extraction | 1 | 2014 | 14 | 0.510 |
Why?
| | Fermentation | 1 | 2014 | 20 | 0.510 |
Why?
| | Recombinant Proteins | 5 | 2016 | 1302 | 0.500 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 347 | 0.490 |
Why?
| | Haplotypes | 1 | 2016 | 474 | 0.480 |
Why?
| | Antigens, Neoplasm | 1 | 2015 | 228 | 0.480 |
Why?
| | Peptide Library | 4 | 2018 | 80 | 0.470 |
Why?
| | Genome | 1 | 2016 | 271 | 0.460 |
Why?
| | Peptides | 2 | 2017 | 879 | 0.460 |
Why?
| | Glucose | 2 | 2015 | 940 | 0.460 |
Why?
| | Evolution, Molecular | 1 | 2017 | 454 | 0.450 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 563 | 0.440 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2014 | 283 | 0.420 |
Why?
| | Models, Biological | 1 | 2019 | 1701 | 0.420 |
Why?
| | Protein Stability | 3 | 2021 | 163 | 0.420 |
Why?
| | Bacterial Proteins | 2 | 2016 | 762 | 0.400 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.400 |
Why?
| | Nanotechnology | 3 | 2009 | 120 | 0.390 |
Why?
| | Models, Genetic | 3 | 2021 | 592 | 0.390 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 141 | 0.380 |
Why?
| | Membrane Proteins | 1 | 2016 | 1048 | 0.370 |
Why?
| | Methanococcus | 2 | 2007 | 9 | 0.370 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1159 | 0.370 |
Why?
| | Promoter Regions, Genetic | 1 | 2014 | 1157 | 0.360 |
Why?
| | Cloning, Molecular | 2 | 2023 | 541 | 0.350 |
Why?
| | Dimerization | 3 | 2023 | 183 | 0.340 |
Why?
| | Algorithms | 2 | 2016 | 1522 | 0.340 |
Why?
| | Protein Conformation | 6 | 2018 | 848 | 0.320 |
Why?
| | Solubility | 3 | 2019 | 235 | 0.320 |
Why?
| | Enzyme Stability | 3 | 2019 | 75 | 0.320 |
Why?
| | Gene Deletion | 1 | 2009 | 359 | 0.310 |
Why?
| | Biomass | 3 | 2016 | 130 | 0.300 |
Why?
| | Two-Hybrid System Techniques | 2 | 2017 | 58 | 0.290 |
Why?
| | Antiviral Agents | 1 | 2012 | 653 | 0.280 |
Why?
| | Genetic Vectors | 2 | 2023 | 302 | 0.250 |
Why?
| | Antibody Affinity | 1 | 2024 | 54 | 0.240 |
Why?
| | Biofouling | 1 | 2023 | 7 | 0.240 |
Why?
| | Ligands | 2 | 2023 | 565 | 0.240 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2063 | 0.230 |
Why?
| | Arabidopsis Proteins | 1 | 2023 | 59 | 0.230 |
Why?
| | Arabidopsis | 1 | 2023 | 69 | 0.220 |
Why?
| | Protein Domains | 2 | 2022 | 212 | 0.220 |
Why?
| | Gene Expression | 3 | 2017 | 1482 | 0.220 |
Why?
| | Thermodynamics | 2 | 2016 | 391 | 0.210 |
Why?
| | Cannabinoids | 1 | 2023 | 115 | 0.210 |
Why?
| | Archaeal Proteins | 3 | 2009 | 49 | 0.210 |
Why?
| | Hormones | 1 | 2022 | 135 | 0.200 |
Why?
| | Drug Stability | 1 | 2021 | 153 | 0.200 |
Why?
| | Drug Approval | 1 | 2021 | 77 | 0.200 |
Why?
| | DNA Breaks, Single-Stranded | 2 | 2020 | 5 | 0.190 |
Why?
| | United States Food and Drug Administration | 1 | 2021 | 174 | 0.190 |
Why?
| | Protein Interaction Mapping | 2 | 2011 | 104 | 0.190 |
Why?
| | Protein Structure, Secondary | 3 | 2016 | 338 | 0.190 |
Why?
| | Databases, Genetic | 1 | 2021 | 215 | 0.190 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2009 | 139 | 0.190 |
Why?
| | Bacteriophage phi X 174 | 1 | 2020 | 4 | 0.180 |
Why?
| | Cats | 1 | 2020 | 204 | 0.180 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 213 | 0.180 |
Why?
| | Penicillin Amidase | 2 | 2009 | 2 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 443 | 0.180 |
Why?
| | Humans | 12 | 2021 | 118257 | 0.170 |
Why?
| | Belladonna Alkaloids | 1 | 2019 | 1 | 0.170 |
Why?
| | Luminescent Agents | 1 | 2019 | 6 | 0.170 |
Why?
| | Genetic Engineering | 1 | 2020 | 82 | 0.170 |
Why?
| | Transition Temperature | 1 | 2019 | 28 | 0.170 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 19 | 0.170 |
Why?
| | Genome, Viral | 1 | 2020 | 123 | 0.170 |
Why?
| | Codon, Nonsense | 1 | 2019 | 38 | 0.170 |
Why?
| | Biocatalysis | 2 | 2015 | 64 | 0.170 |
Why?
| | Pertussis Toxin | 1 | 2018 | 27 | 0.160 |
Why?
| | Pertussis Vaccine | 1 | 2018 | 21 | 0.160 |
Why?
| | Flow Cytometry | 3 | 2018 | 1072 | 0.160 |
Why?
| | Models, Chemical | 2 | 2010 | 274 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2018 | 124 | 0.150 |
Why?
| | Bordetella pertussis | 1 | 2017 | 2 | 0.150 |
Why?
| | Adenylate Cyclase Toxin | 1 | 2017 | 8 | 0.150 |
Why?
| | Acetamides | 1 | 2017 | 26 | 0.150 |
Why?
| | Aspergillus niger | 1 | 2017 | 9 | 0.150 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2017 | 16 | 0.150 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 15 | 0.150 |
Why?
| | Hydrolysis | 1 | 2017 | 176 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2019 | 300 | 0.150 |
Why?
| | DNA Restriction Enzymes | 1 | 2016 | 53 | 0.150 |
Why?
| | Amides | 1 | 2017 | 86 | 0.150 |
Why?
| | Cell Separation | 1 | 2018 | 293 | 0.140 |
Why?
| | Substrate Specificity | 1 | 2017 | 369 | 0.140 |
Why?
| | DNA, Plant | 1 | 2016 | 12 | 0.140 |
Why?
| | Genes, Bacterial | 1 | 2016 | 161 | 0.140 |
Why?
| | Amino Acid Substitution | 1 | 2017 | 275 | 0.140 |
Why?
| | Lipomyces | 1 | 2015 | 1 | 0.140 |
Why?
| | Animals | 5 | 2021 | 33152 | 0.140 |
Why?
| | Glucose-6-Phosphate | 1 | 2015 | 6 | 0.140 |
Why?
| | Area Under Curve | 1 | 2016 | 293 | 0.140 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 522 | 0.130 |
Why?
| | HIV | 1 | 2017 | 209 | 0.130 |
Why?
| | DNA, Neoplasm | 1 | 2016 | 153 | 0.130 |
Why?
| | Protein Transport | 1 | 2017 | 407 | 0.130 |
Why?
| | Surface Properties | 1 | 2016 | 397 | 0.130 |
Why?
| | Cellulose | 1 | 2015 | 64 | 0.130 |
Why?
| | ROC Curve | 1 | 2016 | 470 | 0.130 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2015 | 58 | 0.130 |
Why?
| | Fungal Proteins | 1 | 2015 | 130 | 0.130 |
Why?
| | DNA, Bacterial | 1 | 2016 | 313 | 0.120 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 309 | 0.120 |
Why?
| | Ribosomes | 1 | 2014 | 146 | 0.120 |
Why?
| | Thermosomes | 2 | 2009 | 2 | 0.110 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 170 | 0.110 |
Why?
| | Kinetics | 3 | 2015 | 1623 | 0.110 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2012 | 14 | 0.110 |
Why?
| | Neutralization Tests | 1 | 2012 | 64 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1787 | 0.110 |
Why?
| | Polymers | 2 | 2023 | 482 | 0.110 |
Why?
| | Static Electricity | 1 | 2012 | 120 | 0.100 |
Why?
| | Genotype | 1 | 2017 | 1870 | 0.100 |
Why?
| | Lipids | 1 | 2015 | 591 | 0.100 |
Why?
| | Computer-Aided Design | 1 | 2011 | 42 | 0.100 |
Why?
| | Dogs | 1 | 2012 | 369 | 0.100 |
Why?
| | Crystallography, X-Ray | 2 | 2015 | 421 | 0.100 |
Why?
| | Base Sequence | 2 | 2020 | 2148 | 0.090 |
Why?
| | Nanowires | 1 | 2009 | 10 | 0.090 |
Why?
| | Protein Renaturation | 1 | 2009 | 4 | 0.090 |
Why?
| | Chaperonins | 1 | 2009 | 5 | 0.090 |
Why?
| | Cell Survival | 1 | 2012 | 1045 | 0.080 |
Why?
| | Methanobacterium | 1 | 2008 | 3 | 0.080 |
Why?
| | Calibration | 1 | 2008 | 134 | 0.080 |
Why?
| | Microscopy, Electron | 1 | 2008 | 412 | 0.080 |
Why?
| | Luminescent Proteins | 1 | 2009 | 173 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 369 | 0.080 |
Why?
| | Nanostructures | 1 | 2008 | 100 | 0.070 |
Why?
| | Chromatography, Gel | 1 | 2007 | 133 | 0.070 |
Why?
| | Circular Dichroism | 1 | 2007 | 139 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 2855 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 913 | 0.070 |
Why?
| | DNA Primers | 1 | 2007 | 532 | 0.070 |
Why?
| | Gene Expression Regulation, Archaeal | 1 | 2005 | 10 | 0.070 |
Why?
| | Chemokines, CC | 1 | 2005 | 30 | 0.070 |
Why?
| | Growth Inhibitors | 1 | 2005 | 43 | 0.070 |
Why?
| | United States | 1 | 2021 | 12491 | 0.060 |
Why?
| | RNA | 1 | 2010 | 830 | 0.060 |
Why?
| | Muscle, Smooth | 1 | 2005 | 157 | 0.060 |
Why?
| | Abscisic Acid | 1 | 2023 | 4 | 0.060 |
Why?
| | Plant Growth Regulators | 1 | 2023 | 3 | 0.060 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.060 |
Why?
| | Archaea | 1 | 2004 | 70 | 0.060 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 136 | 0.050 |
Why?
| | Protein Multimerization | 2 | 2015 | 161 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2855 | 0.050 |
Why?
| | Immunoglobulin Light Chains | 1 | 2021 | 35 | 0.050 |
Why?
| | Vero Cells | 1 | 2021 | 69 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 142 | 0.050 |
Why?
| | Antibody Formation | 1 | 2021 | 275 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2020 | 70 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 625 | 0.040 |
Why?
| | Vaccines, Acellular | 1 | 2018 | 2 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1590 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2021 | 538 | 0.040 |
Why?
| | Protein Subunits | 1 | 2018 | 210 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1622 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2021 | 767 | 0.040 |
Why?
| | Conserved Sequence | 1 | 2017 | 219 | 0.040 |
Why?
| | Manganese | 1 | 2015 | 53 | 0.030 |
Why?
| | Proline | 1 | 2015 | 71 | 0.030 |
Why?
| | Magnesium | 1 | 2015 | 150 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 329 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 334 | 0.030 |
Why?
| | Heat-Shock Proteins | 2 | 2005 | 128 | 0.030 |
Why?
| | Lung | 1 | 2005 | 3623 | 0.030 |
Why?
| | Hydrogen Bonding | 1 | 2011 | 146 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 178 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2010 | 146 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 528 | 0.020 |
Why?
| | Amoxicillin | 1 | 2009 | 20 | 0.020 |
Why?
| | Methanol | 1 | 2009 | 35 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2009 | 107 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2009 | 178 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 822 | 0.020 |
Why?
| | Water | 1 | 2009 | 422 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| | Oncostatin M | 1 | 2005 | 5 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 22 | 0.020 |
Why?
| | Cold Temperature | 1 | 2005 | 130 | 0.020 |
Why?
| | Genome, Archaeal | 1 | 2004 | 13 | 0.020 |
Why?
| | Interleukin-13 | 1 | 2005 | 135 | 0.020 |
Why?
| | Drug Synergism | 1 | 2005 | 338 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2005 | 216 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2004 | 59 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2005 | 288 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2005 | 186 | 0.010 |
Why?
| | Hot Temperature | 1 | 2005 | 333 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19594 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 817 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 980 | 0.010 |
Why?
| | Trans-Activators | 1 | 2005 | 373 | 0.010 |
Why?
| | Temperature | 1 | 2005 | 621 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1186 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2005 | 501 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 817 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1322 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1343 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 2657 | 0.010 |
Why?
| | Adult | 1 | 2018 | 31325 | 0.010 |
Why?
| | Male | 1 | 2021 | 57476 | 0.010 |
Why?
|
|
Whitehead's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|